Reina Sasaki-Tanaka
Overview
Explore the profile of Reina Sasaki-Tanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanda T, Sasaki-Tanaka R, Kimura N, Abe H, Yoshida T, Hayashi K, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076514
Patients with chronic cholestatic liver diseases often experience itch and struggle with this symptom. We discuss the mechanism of itch in patients with chronic cholestatic liver diseases, such as primary...
2.
3.
Kanda T, Sasaki-Tanaka R, Tsuchiya A, Terai S
World J Hepatol
. 2025 Jan;
17(1):99209.
PMID: 39871910
Hepatitis B virus (HBV) infection causes acute and chronic hepatitis, compensated and decompensated cirrhosis, and hepatocellular carcinoma worldwide. The actual status of HBV infection and its treatment in certain regions...
4.
Kanda T, Sasaki-Tanaka R, Terai S
Hepatol Int
. 2024 Jul;
18(4):1090-1092.
PMID: 38951373
No abstract available.
5.
Kanda T, Li T, Takahashi M, Nagashima S, Primadharsini P, Kunita S, et al.
Hepatol Res
. 2024 Jun;
54(8):1-30.
PMID: 38874115
Acute hepatitis E was considered rare until reports emerged affirming the existence of hepatitis E virus (HEV) genotypes 3 and 4 infections in Japan in the early 2000s. Extensive studies...
6.
Uehara K, Kanda T, Arima S, Totsuka M, Honda M, Masuzaki R, et al.
Med Int (Lond)
. 2024 May;
4(4):38.
PMID: 38799006
In certain cases, it is difficult to distinguish hepatic sarcoidosis from malignant lymphoma or drug-induced liver injury and to select the proper treatment for this condition. The present study describes...
7.
Kanda T, Sasaki-Tanaka R, Terai S
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791491
The human genome encodes at least 500 protein kinases, and among them, there are at least 90 tyrosine kinases [...].
8.
Arima S, Kanda T, Totsuka M, Honda M, Kanezawa S, Sasaki-Tanaka R, et al.
Med Int (Lond)
. 2024 Apr;
4(3):23.
PMID: 38595809
Hepatocellular carcinoma (HCC) is a common malignancy with a poor prognosis, particularly in patients with advanced-stage disease, elderly individuals and/or in those with poor liver function. Immune checkpoint inhibitor-containing therapies,...
9.
Kanda T, Arima S, Sasaki-Tanaka R, Totsuka M, Honda M, Masuzaki R, et al.
Med Int (Lond)
. 2024 Mar;
4(3):22.
PMID: 38550575
Hepatitis E virus (HEV) infection occasionally causes acute-on-chronic liver failure in patients with alcohol-associated cirrhosis. These reports have been published mainly from highly HEV genotype 1-endemic countries. The present study...
10.
Kanda T, Sasaki-Tanaka R, Ishii K, Suzuki R, Inoue J, Tsuchiya A, et al.
Hepatol Res
. 2023 Oct;
54(1):4-23.
PMID: 37906585
In 2018, there was a hepatitis A outbreak in Japan, and hepatitis A virus (HAV) infection is considered a sexually transmitted disease. In general, patients with hepatitis A should be...